differences in molecular pathologic characteristics of pancreatic adenocarcinoma between egyptian and moroccan patients
نویسندگان
چکیده
introduction : pancreatic cancer has not been well studied, especially in developing countries. materials and methods : we studied the variations in genetic mutations in pancreatic adenocarcinoma between moroccan and egyptian populations. the molecular pathology of 30 tumors from a large hospital in casablanca, morocco were examined and compared with the findings of 44 tumors from the gharbiah governate in egypt. k-ras mutations in codons12 and 13 in addition to p53 mutations in exons 5-8 were evaluated. results : overall, differences in the rates of k-ras mutations were not statistically significant (48.00 and 34.09%, respectively); however differences in rates of p53 mutations were statistically significant with p53 mutations more common in moroccan tumors than in egyptian tumors (46.67 and 16.28%, respectively). gtmutations of the k-ras gene were most commonly seen egyptian tumors, whereas gamutations were the most common type of mutations in moroccan tumors. logistic regression analysis showed that a p53 mutation in any exon as well as a p53 mutation in exon 5 predicted the country of residence and those mutations occurred more frequently in moroccan patients. conclusion : our study shows that differences exist within the arab population in the molecular pathology of both the k-ras and p53 genes. further studies are necessary to clarify the differences in molecular pathways of pancreatic cancer in the middle east and to investigate the role of environmental and/or genetic factors related to those pathways.
منابع مشابه
Differences in Molecular Pathologic Characteristics of Pancreatic Adenocarcinoma between Egyptian and Moroccan Patients.
INTRODUCTION Pancreatic cancer has not been well studied, especially in developing countries. MATERIALS AND METHODS We studied the variations in genetic mutations in pancreatic adenocarcinoma between Moroccan and Egyptian populations. The molecular pathology of 30 tumors from a large hospital in Casablanca, Morocco were examined and compared with the findings of 44 tumors from the Gharbiah Go...
متن کاملDiffering molecular pathology of pancreatic adenocarcinoma in Egyptian and United States patients.
Variations in genetic mutations in pancreatic carcinoma between different populations have not been studied extensively, especially in developing countries where pancreatic cancer is rare. We studied the molecular pathology of 44 pancreatic carcinomas from patients residing in a heavily polluted region in the Nile River delta and compared the findings with tumors from 44 United States (US) pati...
متن کاملMolecular Characteristics of Pancreatic Ductal Adenocarcinoma
Pancreatic cancer is an almost universally lethal disease and despite extensive research over the last decades, this has not changed significantly. Nevertheless, much progress has been made in understanding the pathogenesis of pancreatic ductal adenocarcinoma (PDAC) suggesting that different therapeutic strategies based on these new insights are forthcoming. Increasing focus exists on designing...
متن کاملeffect of bataine and sulphate supplement on wool and milk characteristics and lambs performance in naine ewes
تعداد 20 رأس میش نژاد نائینی 6+-24 ماهه، با میانگین وزن 2/3-+40 کیلوگرم، همراه با 20 رأس بره های آنها در قالب طرح کاملا تصادفی اثر بتائین و مکمل سولفات بر خصوصیات شیر و پشم و عملکرد بره ها بررسی شد. میش ها بطور تصادفی در چهار تیمار قرار گرفتند. تیمارها عبارت بودند از: 1-گروه شاهد 2-بتائین (05/0 درصد ماده خشک) 3-سولفات (24/0 سولفور درصد ماده خشک 4-بتائین هرماه با سولفات. جیره غذائی طبق nrc با مح...
15 صفحه اولMolecular pathobiology of pancreatic adenocarcinoma.
Pancreatic adenocarcinoma is a major cause of cancer death in the United States. Most cases are sporadic and are discovered at late stage when they are not curable by surgery. Information about the molecular biology of pancreatic adenocarcinoma has increased significantly in the last five years with the identification of alterations in the K-ras proto-oncogene and the p16INK4a, p53, FHIT, and D...
متن کاملPost-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.
BACKGROUND Neoadjuvant chemoradiation before surgery is an emerging treatment modality for pancreatic ductal adenocarcinoma (PDAC). However, analysis of prognostic factors is limited for patients with PDAC treated with neoadjuvant chemoradiation and pancreaticoduodenectomy (PD). METHODS The study population was comprised of 240 consecutive patients with PDAC who received neoadjuvant chemoradi...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
middle east journal of cancerجلد ۱، شماره ۱، صفحات ۲۷-۰
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023